Redhawk Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
LMFP
FWIA
DLA
AAMU
ORIO
CNB
UBP
Redhawk Wealth Advisors's BMY Position: Q2 2026 in Review
Redhawk Wealth Advisors increased its Bristol-Myers Squibb (BMY) stake by 320% in Q2 2026, buying an estimated $753K and bringing the position to 17,209 shares worth $992K. The position accounts for 0.1% of the portfolio, ranked #183.
Redhawk Wealth Advisors first reported a position in BMY in Q2 2019 and has held it in 16 quarters since. The position peaked at $1.33M in Q1 2023. 500 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Redhawk Wealth Advisors held 17,209 shares of Bristol-Myers Squibb worth $992K as of Q2 2026.
- Redhawk Wealth Advisors bought 13,108 Bristol-Myers Squibb shares in Q2 2026, an estimated $753K.
- Bristol-Myers Squibb made up 0.1% of Redhawk Wealth Advisors's portfolio in Q2 2026, its #183 holding.
- Redhawk Wealth Advisors first reported a position in Bristol-Myers Squibb in Q2 2019 and has held it in 16 quarters since.
- Redhawk Wealth Advisors's Bristol-Myers Squibb position peaked at $1.33M in Q1 2023.
- 500 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Redhawk Wealth Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.